Skip to main content

Table 6 Risk of metabolic syndrome, increased risk of individual metabolic syndrome components and other health factors among adult (19+ yrs) consumers and non-consumers of orange juice

From: 100% Orange juice consumption is associated with better diet quality, improved nutrient adequacy, decreased risk for obesity, and improved biomarkers of health in adults: National Health and Nutrition Examination Survey, 2003-2006

Risk

OR ± SE

LCL, UCL

p-Value

OR ± SE

LCL, UCL

p-Value

OR ± SE

LCL, UCL

p-Value

All

Female

Male

MetS

0.93 ± 0.13

0.71, 1.22

0.5790

1.41 ± 0.28

0.96, 2.07

0.0795

0.64 ± 0.12

0.45,0.91

0.0119

Elevated BP

0.98 ± 0.07

0.85, 1.13

0.7586

0.98 ± 0.15

0.73, 1.31

0.8948

0.95 ± 0.12

0.75, 1.22

0.7078

High Glucose

0.96 ± 0.10

0.78, 1.18

0.6772

1.08 ± 0.17

0.79, 1.47

0.6180

0.82 ± 0.11

0.64, 1.06

0.1361

High TG

1.11 ± 0.13

0.89, 1.39

0.3575

1.41 ± 0.25

1.00, 1.99

0.0503

0.91 ± 0.11

0.72, 1.15

0.4474

Elevated WC

0.98 ± 0.15

0.73, 1.33

0.9067

1.09 ± 0.24

0.72, 1.66

0.6890

0.83 ± 0.15

0.59, 1.18

0.3052

Low HDL-C

0.92 ± 0.08

0.78, 1.09

0.3518

1.08 ± 0.11

0.89 1.31

0.4271

0.77 ± 0.10

0.61, 0.99

0.0406

Obese

0.79 ± 0.08

0.65, 0.95

0.0116

0.76 ± 0.10

0.59, 0.97

0.0289

0.79 ± 0.09

0.64, 0.97

0.0276

Overweight

1.13 ± 0.07

0.99, 1.28

0.0699

1.18 ± 0.10

0.99, 1.39

0.0581

1.07 ± 0.09

0.91, 1.26

0.3976

Overweight or Obese

0.89 ± 0.07

0.76, 1.04

0.1437

0.88 ± 0.09

0.73, 1.08

0.2216

0.85 ± 0.09

0.69, 1.06

0.1461

High LDL-C

0.82 ± 0.10

0.66, 1.03

0.0908

0.76 ± 0.12

0.57, 1.03

0.0783

0.85 ± 0.14

0.63, 1.16

0.3163

  1. * Reference group: Non-consumers of orange juice with odds ratio set at 1.0.
  2. All Metabolic Syndrome Components: Elevated Waist Circumference ≥102 cm in men or ≥88 cm in women; Elevated Triglycerides ≥150 mg/dL or taking medication for Elevated Triglycerides (Antihyperlipidemic Agents or Nicotinic Acid Derivatives); Reduced HDL-C <40 mg/dL in men or <50 mg/dL in women or taking medication for Reduced HDL-C (Antihyperlipidemic Agents or Nicotinic Acid Derivatives); Elevated BP ≥130 mmHg Systolic or ≥85 mmHg Diastolic or taking medication for Elevated BP (Antihypertensive Combinations); Elevated Fasting Glucose ≥100 mg/dL or taking medication for Elevated Glucose (Antidiabetic Agents); Metabolic Syndrome (≥3 risk factors above). Other risk factors: Elevated LDL-C ≥100 mg/dL; Overweight BMI ≥25 and <30; Obese BMI ≥30; Overweight or Obese BMI ≥25.
  3. Abbreviations: OR = odds Ratio; LCL = lower confidence level; UCL = upper confidence level; SE = standard error; MetS = metabolic syndrome; BP = blood pressure; TG = triglycerides; WC = waist circumference; HDL-C = high density lipoprotein-cholesterol; LDL-C = low density lipoprotein-cholesterol.